EUCTR2006-005287-94-AT进行中（未招募）不适用
Impact of n-3 Polyunsaturated Fatty Acids on Adipose Tissue Inflammation in Morbidly Obese Patients - n-3 PUFA in Obesity
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •non-diabetic morbidly obese patients (BMI > 40 kg/m2) supposed to undergo bariatric surgery; age 20-65 yrs;
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Acute illness within the last two weeks
- •Known diabetes mellitus or current anti-diabetic medication
- •Acquired immunodeficiency (HIV infection)
- •Hepatitis or other significant liver disease
- •Severe or untreated cardiovascular, renal, pulmonary disease
- •Untreated or inadequately treated clinically significant thyroid disease
- •Active malignant disease
- •Inborn or acquired bleeding disorder including warfarin treatment
- •Pregnancy or breast feeding
- •Drug intolerability that prohibits the use of the study drug
研究者
相似试验
已完成
2 期
n-3 Polyunsaturated Fatty Acids in ObesityAdipose Tissue InflammationMorbid ObesityNCT00760760Medical University of Vienna55
进行中（未招募）
不适用
The effects of omega-3 fatty acids on the kidney, heart and vascular system in patients who has received a kidney transplantRenal transplantationEUCTR2012-004992-37-NOSouth-Eastern Norway Regional Health Authority132
已完成
不适用
The effect of omega-3 in non-alcoholic fatty liver diseaseTopic: Metabolic and EndocrineSubtopic: Metabolic and Endocrine (all Subtopics)Disease: Metabolic & Endocrine (not diabetes)Digestive SystemNon-alcoholic fatty liver diseaseISRCTN81956288niversity of Nottingham (UK)58
进行中（未招募）
1 期
The Effect of omega-3 polyunsaturated Fatty Acid Supplements on Microvolt T-Alternans in Patients with Ventricular ArrythmiaEUCTR2005-002688-10-GBniversity of Dundee
招募中
不适用
Effect of Omega-3 polyunsaturated fatty acids in patients with heart failure and preserved ejection fractioheart failure and preserved ejection fractionJPRN-UMIN000012603Kanagawa Cardiovascular and Respiratory Center40